Regulation of Bile Acid Synthesis by Nuclear Receptors
核受体对胆汁酸合成的调节
基本信息
- 批准号:9176050
- 负责人:
- 金额:$ 38.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-05-01 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAdenovirusesAffectAgonistAnimal ExperimentsAnimalsBacteriaBariatricsBile Acid Biosynthesis PathwayBile AcidsBinding SitesBiological AssayBypassCYP8B1 geneCarbohydratesCholesterolChromatinCircadian RhythmsCollaborationsColonDataDiabetes MellitusDietDisease remissionDyslipidemiasEatingEnergy MetabolismFGF21 geneFastingFatty LiverFatty acid glycerol estersG-Protein-Coupled ReceptorsGPBAR1 geneGastrectomyGastric BypassGene ExpressionGenesGeneticGluconeogenesisGlucose IntoleranceGrowthHepaticHigh Fat DietHomeostasisHydrophobicityHyperglycemiaIACUCImpairmentInflammatory Bowel DiseasesInsulin ResistanceLinkLipidsLiverLiver diseasesMalignant NeoplasmsMetabolicMetabolic DiseasesMetabolismMethylationMichiganMolecularMusNon-Insulin-Dependent Diabetes MellitusNuclear Hormone ReceptorsNuclear ReceptorsNutrientObesityOperative Surgical ProceduresPathway interactionsPatientsPharmaceutical PreparationsPlayPrecipitationPredispositionProtocols documentationReceptor SignalingRegulationReporterResearch PersonnelRoleSerumSignal TransductionSomatotropinStat5 proteinTaxonTestingTherapeuticTimeUniversitiesWild Type Mouseadenoviral-mediatedbariatric surgerybasechromatin immunoprecipitationepigenetic regulationfeedingfeeding scheduleglucagon-like peptideglucagon-like peptide 1glucose metabolismglucose toleranceglycemic controlgut microbiomegut microbiotahormone regulationileumimprovedin vivoinsulin tolerancelipid metabolismliver inflammationliver metabolismmalemicrobialmicrobiomenon-alcoholic fatty livernoveloverexpressionoxysterol 7-alpha-hydroxylasepromoterresponsetime usetranscriptome sequencingwestern diet
项目摘要
3URJUDP'LUHFWRU3ULQFLSDO,QYHVWLJDWRU /DVW)LUVW0LGGOH Chiang, John Y. L.
352-(&76800$5< 6HHLQVWUXFWLRQV
Type 2 diabetes and obesity is associated with dyslipidemia, hyperglycemia and insulin resistance. Hepatic
steatosis contributes to insulin resistance and non-alcoholic fatty liver disease. Bile acids play a key role in
regulation of lipid, glucose and energy metabolism by activating a nuclear hormone receptor FXR, and G
protein-coupled receptor TGR5. Our central hypothesis is that nutrients, growth hormone, circadian rhythm
and gut microbiota regulate bile acid synthesis to maintain metabolic homeostasis, and impairment of this
regulatory response contributes to dyslipidemia, glucose intolerance, insulin resistance, fatty liver disease
and obesity. Specific aim 1 will study the role of bile acid receptor signaling in regulation of hepatic
metabolism. The mechanism of growth hormone-STAT5 regulation of bile acid synthesis and a male
predominant Cyp7b1 will be studied using reporter assay and chromatin immuno- precipitation assay to
identify STAT5 binding sites and epigenetic regulation of Cyp7b1 promoter by STAT5. Tgr5-/-, Cyp7a1-/-
and adenovirus-Cyp8b1 over-expressed mice with different bile acid composition and Cyp7a1, Cyp8b1 and
cyp7b1 expression will be used to study growth hormone regulation. Specific aim 2 will study the role of bile
acid receptor signaling in fatty liver, insulin resistance and diabetes. The mechanism of FXR and TGR5 in
GLP-1 secretion and glucose metabolism will be studied. Tgr5-/- mice will be used to study effect of vertical
sleeve gastrectomy on improving insulin resistance, dyslipidemia and microbiome before and after surgery.
Specific aim 3 will study circadian rhythm of bile acid synthesis in metabolic homeostasis. The liver-gut
microbiota axis plays a critical role in bile acid metabolism and disturbance of circadian rhythm is linked to
metabolic diseases. Dysbiosis is associated with obesity, and inflammatory bowel diseases. Tgr5-/-, FXR-/-
and Cyp7a1-/- with different bile acid pool size and/or composition will be used for time-restricted feeding of
Western high fat/high cholesterol diet to study bile acid metabolism and gut microbiome by RNA
sequencing. Cyp7a1-/-, Fxr-/-, and Tgr5-/- will be used to determine how time-restricted feeding in day time
or night time affect affect hepatic gene rhythms and overall bile acid homeostasis.
5(/(9$1&( 6HHLQVWUXFWLRQV
Understanding the underlying molecular mechanism of bile acid signaling in liver metabolism and
inflammation is critical for developing bile acid-based therapeutic drugs for treating metabolic liver diseases.
Study liver to gut axis and circadian disruption on gut microbiome and bile acid metabolism, and the role of
TGR5 signaling on diabetes remission after gastric bypass is highly relevant to liver diseases and treatment.
352-(&73(5)250$1&(6,7( 6 LIDGGLWLRQDOVSDFHLVQHHGHGXVH3URMHFW3HUIRUPDQFH6LWH)RUPDW3DJH
3URJUDP'LUHFWRU 3ULQFLSDO,QYHVWLJDWRU /DVW)LUVW0LGGOH Chiang,John Y. L.
352-(&76800$5< 6HHLQVWUXFWLRQV
2型糖尿病和肥胖与血脂异常、高血糖和胰岛素抵抗有关。肝
脂肪变性导致胰岛素抵抗和非酒精性脂肪肝病。胆汁酸在
通过激活核激素受体FXR和G调节脂质、葡萄糖和能量代谢
蛋白偶联受体TGR 5。我们的核心假设是营养素,生长激素,昼夜节律
和肠道微生物群调节胆汁酸合成以维持代谢稳态,
调节反应导致血脂异常、葡萄糖耐受不良、胰岛素抵抗、脂肪肝
和肥胖。具体目标1将研究胆汁酸受体信号转导在肝细胞凋亡调控中的作用。
新陈代谢.生长抑素-STAT 5调控胆汁酸合成的机制及雄性
主要Cyp 7 b1将使用报告分析和染色质免疫沉淀分析进行研究,
鉴定STAT 5结合位点和STAT 5对Cyp 7 b1启动子表观遗传调控。Tgr 5-/-,Cyp7a1-/-
和腺病毒-Cyp 8b 1过表达的小鼠具有不同的胆汁酸组成和Cyp 7a 1,Cyp 8b 1和
CYP 7 B1表达将用于研究生长激素调节。具体目标2将研究胆汁的作用
脂肪肝、胰岛素抵抗和糖尿病中的酸性受体信号传导。FXR和TGR 5在乳腺癌中的作用机制
将研究GLP-1分泌和葡萄糖代谢。Tgr 5-/-小鼠将用于研究垂直注射的效果。
袖状胃切除术改善胰岛素抵抗,血脂异常和手术前后的微生物组。
具体目标3将研究代谢稳态中胆汁酸合成的昼夜节律。肝肠
微生物群轴在胆汁酸代谢中起着关键作用,昼夜节律的紊乱与
代谢性疾病生态失调与肥胖和炎症性肠病有关。Tgr 5-/-、FXR-/-
和Cyp 7a 1-/-具有不同的胆汁酸池大小和/或组成将用于时间限制的喂养
西方高脂肪/高胆固醇饮食通过RNA研究胆汁酸代谢和肠道微生物组
测序Cyp 7a 1-/-、Fxr-/-和Tgr 5-/-将用于确定在白天时间限制喂养
或夜间影响肝脏基因节律和整体胆汁酸稳态。
5(/(9$1&(6HHLQVWUXFWLRQV
了解肝脏代谢中胆汁酸信号传导的潜在分子机制,
炎症对于开发用于治疗代谢性肝病的基于胆汁酸的治疗药物至关重要。
研究肝-肠轴和昼夜节律对肠道微生物组和胆汁酸代谢的破坏,以及
胃旁路术后糖尿病缓解的TGR 5信号传导与肝脏疾病和治疗高度相关。
352-(&73(5)250$1&(6,7(6 LIDGGLWLRQDOVSDFHLVQHHGHGXVH3URMHFW3HUIRW3QFH6LWH)RUPDW3DJH
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN Y. L. CHIANG其他文献
JOHN Y. L. CHIANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN Y. L. CHIANG', 18)}}的其他基金
Regulation of Bile Acid Synthesis by Nuclear Receptors
核受体对胆汁酸合成的调节
- 批准号:
9923618 - 财政年份:2016
- 资助金额:
$ 38.77万 - 项目类别:
Regulation of Bile Acid Synthesis by Nuclear receptors
核受体对胆汁酸合成的调节
- 批准号:
7802989 - 财政年份:2000
- 资助金额:
$ 38.77万 - 项目类别:
Regulation of Bile Acid Synthesis by Nuclear Receptors
核受体对胆汁酸合成的调节
- 批准号:
8454527 - 财政年份:2000
- 资助金额:
$ 38.77万 - 项目类别:
Regulation of Bile Acid Synthesis by Nuclear receptors
核受体对胆汁酸合成的调节
- 批准号:
7624591 - 财政年份:2000
- 资助金额:
$ 38.77万 - 项目类别:
Regulation of Bile Acid Synthesis by Nuclear Receptors
核受体对胆汁酸合成的调节
- 批准号:
8107257 - 财政年份:2000
- 资助金额:
$ 38.77万 - 项目类别:
Regulation of Bile Acid Synthesis by Nuclear receptors
核受体对胆汁酸合成的调节
- 批准号:
7406056 - 财政年份:2000
- 资助金额:
$ 38.77万 - 项目类别:
Regulation of Bile Acid Synthesis by Nuclear Receptors
核受体对胆汁酸合成的调节
- 批准号:
8829229 - 财政年份:2000
- 资助金额:
$ 38.77万 - 项目类别:
Regulation of Bile Acid Synthesis by Nuclear Receptors
核受体对胆汁酸合成的调节
- 批准号:
8661752 - 财政年份:2000
- 资助金额:
$ 38.77万 - 项目类别:
Regulation of Bile Acid Synthesis by Nuclear Receptors
核受体对胆汁酸合成的调节
- 批准号:
8227970 - 财政年份:2000
- 资助金额:
$ 38.77万 - 项目类别:
Regulation of Bile Acid Synthesis by Nuclear receptors
核受体对胆汁酸合成的调节
- 批准号:
7196124 - 财政年份:2000
- 资助金额:
$ 38.77万 - 项目类别:
相似海外基金
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
- 批准号:
10436626 - 财政年份:2021
- 资助金额:
$ 38.77万 - 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10557162 - 财政年份:2021
- 资助金额:
$ 38.77万 - 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
- 批准号:
21K08199 - 财政年份:2021
- 资助金额:
$ 38.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10330464 - 财政年份:2021
- 资助金额:
$ 38.77万 - 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
- 批准号:
9807741 - 财政年份:2019
- 资助金额:
$ 38.77万 - 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2018
- 资助金额:
$ 38.77万 - 项目类别:
Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
- 批准号:
18K15937 - 财政年份:2018
- 资助金额:
$ 38.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2017
- 资助金额:
$ 38.77万 - 项目类别:
Discovery Grants Program - Individual
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
- 批准号:
16K09118 - 财政年份:2016
- 资助金额:
$ 38.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
- 批准号:
1813152 - 财政年份:2016
- 资助金额:
$ 38.77万 - 项目类别:
Studentship